AM
Amanta Healthcare Ltd (AMANTA)
₹218.00
Mkt cap
₹864 Cr
P/E ratio
47.10
P/B
3.71
Div yield
0.00%
ROE
10.30%
ROCE
11.60%
EPS (TTM)
₹4.63
Book value
₹59
52W range
92–246
Sector
Healthcare
Price history
Previous close
Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products. [1]
NSE AMANTABSE 544502
Health check
Mixed
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsBullish
52-week range
−11.27% from high₹218
₹92+136.96% from low₹246
Current
₹218.00
Prev close
₹239.08
Day
−8.82%
Price performance
1D
−8.82%
1W
−7.02%
1M
+32.22%
3M
+16.88%
6M
+72.69%
1Y
+81.94%
YTD
+98.65%
Financials
Revenue, profit & margin
P/E ratio
47.1×
AMANTA is 45% above the sector median of 32.5×
AMANTA47.1×
Sector median32.5×
| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 68.10 | 66.73 | 67.81 | 72.06 | 65.31 | 70.89 | 74.49 | 76.99 | 68.80 | 83.13 | |
| YoY Sales growth | -4.10% | +6.23% | +9.85% | +6.84% | +5.34% | +17.27% | |||||
| Expenses | 54.70 | 52.85 | 52.75 | 53.10 | 50.41 | 56.24 | 59.13 | 62.03 | 54.26 | 65.94 | |
| Operating Profit | 13.40 | 13.88 | 15.06 | 18.96 | 14.90 | 14.65 | 15.36 | 14.96 | 14.54 | 17.19 | |
| OPM % | 19.68% | 20.80% | 22.21% | 26.31% | 22.81% | 20.67% | 20.62% | 19.43% | 21.13% | 20.68% | |
| Other Income | 0.15 | 0.21 | 0.87 | 0.16 | 0.96 | -2.56 | 0.68 | 1.66 | 0.64 | 0.76 | |
| Interest | 9.45 | 6.32 | 5.90 | 6.28 | 6.29 | 5.15 | 5.06 | 4.25 | 6.00 | 5.84 | |
| Depreciation | 4.60 | 4.60 | 4.51 | 4.69 | 4.64 | 4.66 | 4.67 | 4.75 | 4.69 | 5.28 | |
| Profit before tax | -0.50 | 3.17 | 5.52 | 8.15 | 4.93 | 2.28 | 6.31 | 7.62 | 4.49 | 6.83 | |
| Tax % | -28.00% | 28.71% | 22.64% | 26.87% | 28.80% | 46.93% | 26.47% | 27.43% | 26.28% | 28.84% | |
| Net Profit | -0.36 | 2.26 | 4.28 | 5.96 | 3.51 | 1.21 | 4.63 | 5.53 | 3.31 | 4.86 | |
| EPS in Rs | -0.12 | 0.78 | 1.48 | 2.07 | 1.22 | 0.31 | 1.19 | 1.42 | 0.85 | 1.25 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202663.80%Promoter
Promoters63.80%
FIIs0.07%0.36
DIIs12.20%0.72
Public23.93%1.09
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,884.90 | 36.70 | 4,51,538 | 0.85% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹11,180.50 | 86.86 | 2,96,807 | 0.27% | 1,127 | +63.57% | 3,676 | +35.40% | 21.97% |
| Torrent Pharma. | ₹4,689.50 | 82.07 | 1,78,180 | 0.81% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,294.60 | 92.69 | 1,24,195 | 0.09% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,200.00 | 26.48 | 1,19,990 | 0.08% | 928 | −27.96% | 7,910 | +29.17% | 21.14% |
| Dr Reddy's Labs | ₹1,390.20 | 41.56 | 1,16,360 | 0.58% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,415.00 | 36.88 | 1,14,518 | 0.92% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| Amanta Healthcar | ₹222.37 | 47.13 | 864 | 0.00% | 5 | +159.89% | 83 | +17.27% | 11.60% |
| Median: 160 Co. | ₹432.20 | 32.47 | 1,987 | 0.08% | 13 | +33.73% | 179 | +21.23% | 14.94% |
Filings
Annual reports1
Concall transcripts11
Credit ratings6
Announcements5
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 18 NovSubmission Of Disclosures Under Regulation 7(2) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015 - Off Market Transfer Of Equity Shares 18 Nov - Form C reports off-market inter-se transfer of equity shares between promoter and promoter group on Nov 17-18, 2026.Company Response On The Spurt In Volume Of Security Across Exchanges 14 Nov - Company denies any undisclosed event behind recent volume surge.Clarification sought from Amanta Healthcare Ltd 13 Nov - Exchange has sought clarification from Amanta Healthcare Ltd on November 13, 2026, with reference to Movement in Volume.Announcement under Regulation 30 (LODR)-Earnings Call Transcript 9 Nov - Transcript of Post Results Conference call held on November 4, 2026






